Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q6PDQ2

Entry ID Method Resolution Chain Position Source
AF-Q6PDQ2-F1 Predicted AlphaFoldDB

92 variants for Q6PDQ2

Variant ID(s) Position Change Description Diseaes Association Provenance
rs47403044 22 A>S No EVA
rs3388863586 72 K>* No EVA
rs3388823666 86 V>E No EVA
rs3388860911 152 G>R No EVA
rs3388863564 153 M>I No EVA
rs3388857211 154 E>* No EVA
rs3388857186 168 L>P No EVA
rs3388855237 207 T>I No EVA
rs3388858340 225 A>S No EVA
rs3388857221 244 P>S No EVA
rs3397312560 246 V>G No EVA
rs3388859596 258 G>S No EVA
rs3388857269 269 G>D No EVA
rs3388850420 270 S>N No EVA
rs3388859668 346 K>T No EVA
rs3397171504 349 E>K No EVA
rs3388862417 377 L>V No EVA
rs3388866766 379 D>N No EVA
rs3388850485 390 L>V No EVA
rs3388823663 405 P>L No EVA
rs3397248251 428 E>A No EVA
rs3396523456 428 E>Q No EVA
rs3388845372 457 C>Y No EVA
rs3397336646 464 Y>C No EVA
rs3397379088 465 H>N No EVA
rs3388823660 508 S>Y No EVA
rs3388854285 528 L>M No EVA
rs3388823655 580 D>N No EVA
rs3388855161 609 G>E No EVA
rs3388836827 626 D>E No EVA
rs3388850498 628 K>R No EVA
rs3388850494 660 F>I No EVA
rs3388863176 679 G>D No EVA
rs3388861977 749 G>R No EVA
rs3388836833 757 F>I No EVA
rs3397248220 767 S>P No EVA
rs3388836832 778 S>Y No EVA
rs3388841933 780 I>F No EVA
rs3396918001 796 V>L No EVA
rs3388863158 957 K>E No EVA
rs3388857202 989 A>T No EVA
rs3388836831 1034 D>V No EVA
rs3388862455 1087 E>V No EVA
rs3388854320 1161 K>M No EVA
rs3388855156 1179 Q>H No EVA
rs3388841956 1180 V>M No EVA
rs3388859619 1185 M>L No EVA
rs3397471366 1225 T>P No EVA
rs3397248248 1226 D>E No EVA
rs3388823628 1261 T>I No EVA
rs3388852012 1271 S>C No EVA
rs3397309130 1315 Y>N No EVA
rs3396524563 1316 E>V No EVA
rs3397322198 1317 Q>P No EVA
rs3388858401 1367 D>G No EVA
rs3397373248 1387 N>D No EVA
rs3396524529 1388 D>E No EVA
rs3397248218 1391 K>E No EVA
rs3388857227 1414 R>Q No EVA
rs3388841930 1417 F>S No EVA
rs3388845412 1432 F>L No EVA
rs3388858425 1433 T>P No EVA
rs3388841907 1439 R>I No EVA
rs3388857196 1502 F>C No EVA
rs13463121 1579 T>S No EVA
rs3388861989 1586 E>V No EVA
rs108857492 1590 P>L No EVA
rs30618367 1593 P>S No EVA
rs30618367 1593 P>T No EVA
rs579699204 1597 T>P No EVA
rs1135381637 1599 P>T No EVA
rs582217170 1605 P>S No EVA
rs235167786 1638 A>P No EVA
rs3388854343 1648 E>A No EVA
rs3388854343 1648 E>G No EVA
rs251765102 1674 D>E No EVA
rs223866560 1676 M>T No EVA
rs3388857201 1677 L>F No EVA
rs261921828 1685 D>E No EVA
rs3388863625 1688 D>N No EVA
rs222786350 1695 S>I No EVA
rs3388859679 1702 N>K No EVA
rs3397379072 1711 L>* No EVA
rs3388863614 1728 T>I No EVA
rs3388858335 1739 W>* No EVA
rs3388866744 1880 R>L No EVA
rs3388863567 1882 P>L No EVA
rs3388858375 1884 V>L No EVA
rs3388863173 1885 A>T No EVA
rs3388862432 1890 M>I No EVA
rs3388823686 1890 M>V No EVA
rs3388823678 1895 I>T No EVA

No associated diseases with Q6PDQ2

3 regional properties for Q6PDQ2

Type Name Position InterPro Accession
domain XPG, N-terminal 1 - 134 IPR006085
domain XPG-I domain 181 - 288 IPR006086
domain Yen1, H3TH domain 286 - 388 IPR037316

Functions

Description
EC Number 3.6.4.12 Acting on ATP; involved in cellular and subcellular movement
Subcellular Localization
  • Nucleus
  • Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
  • Associates with centrosomes in interphase
  • Localizes to sites of DNA damage in a manner dependent on ZMYND8 and ZNF687
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

10 GO annotations of cellular component

Name Definition
centrosome A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle.
chromatin The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome.
chromosome, telomeric region The end of a linear chromosome, required for the integrity and maintenance of the end. A chromosome telomere usually includes a region of telomerase-encoded repeats the length of which rarely exceeds 20 bp each and that permits the formation of a telomeric loop (T-loop). The telomeric repeat region is usually preceded by a sub-telomeric region that is gene-poor but rich in repetitive elements. Some telomeres only consist of the latter part (for eg. D. melanogaster telomeres).
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
NuRD complex An approximately 2 MDa multi-subunit complex that exhibits ATP-dependent chromatin remodeling activity in addition to histone deacetylase (HDAC) activity, and has been shown to establish transcriptional repression of a number of target genes in vertebrates, invertebrates and fungi. Amongst its subunits, the NuRD complex contains histone deacetylases, histone binding proteins and Mi-2-like proteins.
protein-containing complex A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
protein-DNA complex A macromolecular complex containing both protein and DNA molecules.
RNA polymerase II transcription regulator complex A transcription factor complex that acts at a regulatory region of a gene transcribed by RNA polymerase II.

12 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
ATP hydrolysis activity Catalysis of the reaction: ATP + H2O = ADP + H+ phosphate. ATP hydrolysis is used in some reactions as an energy source, for example to catalyze a reaction or drive transport against a concentration gradient.
ATP-dependent chromatin remodeler activity An activity, driven by ATP hydrolysis, that modulates the contacts between histones and DNA, resulting in a change in chromosome architecture within the nucleosomal array, leading to chromatin remodeling.
chromatin binding Binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
DNA helicase activity Unwinding of a DNA helix, driven by ATP hydrolysis.
DNA-binding transcription factor binding Binding to a DNA-binding transcription factor, a protein that interacts with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription.
histone binding Binding to a histone, any of a group of water-soluble proteins found in association with the DNA of eukaryotic or archaeal chromosomes. They are involved in the condensation and coiling of chromosomes during cell division and have also been implicated in gene regulation and DNA replication. They may be chemically modified (methylated, acetlyated and others) to regulate gene transcription.
histone deacetylase binding Binding to histone deacetylase.
metal ion binding Binding to a metal ion.
RNA polymerase II-specific DNA-binding transcription factor binding Binding to a sequence-specific DNA binding RNA polymerase II transcription factor, any of the factors that interact selectively and non-covalently with a specific DNA sequence in order to modulate transcription.
transcription coregulator binding Binding to a transcription coregulator, a protein involved in regulation of transcription via protein-protein interactions with transcription factors and other transcription regulatory proteins. Cofactors do not bind DNA directly, but rather mediate protein-protein interactions between regulatory transcription factors and the basal transcription machinery.

9 GO annotations of biological process

Name Definition
chromatin remodeling A dynamic process of chromatin reorganization resulting in changes to chromatin structure. These changes allow DNA metabolic processes such as transcriptional regulation, DNA recombination, DNA repair, and DNA replication.
histone deacetylation The modification of histones by removal of acetyl groups.
negative regulation of DNA-templated transcription Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
negative regulation of gene expression Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA).
negative regulation of transcription by RNA polymerase II Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
positive regulation of DNA-templated transcription Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
regulation of cell fate specification Any process that mediates the adoption of a specific fate by a cell.
regulation of stem cell differentiation Any process that modulates the frequency, rate or extent of stem cell differentiation.
terminal button organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a terminal button. A terminal button is the terminal inflated portion of the axon, containing the specialized apparatus necessary to release neurotransmitters.

8 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O16102 Chd3 Chromodomain-helicase-DNA-binding protein 3 Drosophila melanogaster (Fruit fly) PR
Q12873 CHD3 Chromodomain-helicase-DNA-binding protein 3 Homo sapiens (Human) PR
Q8TDI0 CHD5 Chromodomain-helicase-DNA-binding protein 5 Homo sapiens (Human) PR
Q14839 CHD4 Chromodomain-helicase-DNA-binding protein 4 Homo sapiens (Human) PR
A2A8L1 Chd5 Chromodomain-helicase-DNA-binding protein 5 Mus musculus (Mouse) PR
P40201 Chd1 Chromodomain-helicase-DNA-binding protein 1 Mus musculus (Mouse) PR
D3ZD32 Chd5 Chromodomain-helicase-DNA-binding protein 5 Rattus norvegicus (Rat) PR
Q22516 chd-3 Chromodomain-helicase-DNA-binding protein 3 homolog Caenorhabditis elegans PR
10 20 30 40 50 60
MASGLGSPSP CSAGSEEEDM DALLNNSLPP PHPENEEDPD EDLSEAETPK LKKKKKPKKP
70 80 90 100 110 120
RDPKIPKSKR QKKELGDSSG EGPEFVEEEE EVALRSDSEG SDYTPGKKKK KKLGPKKEKK
130 140 150 160 170 180
SKSKRKEEEE EEDEDDDSKE PKSSAQLLED WGMEDIDHVF SEEDYRTLTN YKAFSQFVRP
190 200 210 220 230 240
LIAAKNPKIA VSKMMMVLGA KWREFSTNNP FKGSSGASVA AAAAAAVAVV ESMVTATEVA
250 260 270 280 290 300
PPPPPVEVPI RKAKTKEGKG PNARRKPKGS PRVPDAKKPK PKKVAPLKIK LGGFGSKRKR
310 320 330 340 350 360
SSSEDDDLDV ESDFDDASIN SYSVSDGSTS RSSRSRKKLR TAKKKKKGEE EVTAVDGYET
370 380 390 400 410 420
DHQDYCEVCQ QGGEIILCDT CPRAYHMVCL DPDMEKAPEG KWSCPHCEKE GIQWEAKEDN
430 440 450 460 470 480
SEGEEILEEV GGDPEEEDDH HMEFCRVCKD GGELLCCDTC PSSYHIHCLN PPLPEIPNGE
490 500 510 520 530 540
WLCPRCTCPA LKGKVQKILI WKWGQPPSPT PVPRPPDADP NTPSPKPLEG RPERQFFVKW
550 560 570 580 590 600
QGMSYWHCSW VSELQLELHC QVMFRNYQRK NDMDEPPSGD FGGDEEKSRK RKNKDPKFAE
610 620 630 640 650 660
MEERFYRYGI KPEWMMIHRI LNHSVDKKGH VHYLIKWRDL PYDQASWESE DVEIQDYDLF
670 680 690 700 710 720
KQSYWNHREL MRGEEGRPGK KLKKVKLRKL ERPPETPTVD PTVKYERQPE YLDATGGTLH
730 740 750 760 770 780
PYQMEGLNWL RFSWAQGTDT ILADEMGLGK TVQTAVFLYS LYKEGHSKGP FLVSAPLSTI
790 800 810 820 830 840
INWEREFEMW APDMYVVTYV GDKDSRAIIR ENEFSFEDNA IRGGKKASRM KKEASVKFHV
850 860 870 880 890 900
LLTSYELITI DMAILGSIDW ACLIVDEAHR LKNNQSKFFR VLNGYSLQHK LLLTGTPLQN
910 920 930 940 950 960
NLEELFHLLN FLTPERFHNL EGFLEEFADI AKEDQIKKLH DMLGPHMLRR LKADVFKNMP
970 980 990 1000 1010 1020
SKTELIVRVE LSPMQKKYYK YILTRNFEAL NARGGGNQVS LLNVVMDLKK CCNHPYLFPV
1030 1040 1050 1060 1070 1080
AAMEAPKMPN GMYDGSALIR ASGKLLLLQK MLKNLKEGGH RVLIFSQMTK MLDLLEDFLE
1090 1100 1110 1120 1130 1140
HEGYKYERID GGITGNMRQE AIDRFNAPGA QQFCFLLSTR AGGLGINLAT ADTVIIYDSD
1150 1160 1170 1180 1190 1200
WNPHNDIQAF SRAHRIGQNK KVMIYRFVTR ASVEERITQV AKKKMMLTHL VVRPGLGSKT
1210 1220 1230 1240 1250 1260
GSMSKQELDD ILKFGTEELF KDEATDGGGD NKEGEDSSVI HYDDKAIERL LDRNQDETED
1270 1280 1290 1300 1310 1320
TELQGMNEYL SSFKVAQYVV REEEMGEEEE VEREIIKQEE SVDPDYWEKL LRHHYEQQQE
1330 1340 1350 1360 1370 1380
DLARNLGKGK RIRKQVNYND GSQEDRDWQD DQSDNQSDYS VASEEGDEDF DERSEAPRRP
1390 1400 1410 1420 1430 1440
SRKGLRNDKD KPLPPLLARV GGNIEVLGFN ARQRKAFLNA IMRYGMPPQD AFTTQWLVRD
1450 1460 1470 1480 1490 1500
LRGKSEKEFK AYVSLFMRHL CEPGADGAET FADGVPREGL SRQHVLTRIG VMSLIRKKVQ
1510 1520 1530 1540 1550 1560
EFEHVNGRWS MPELAEVEEN KKMSQPGSPS PKTPTPSTPG DTQPNTPAPV PPAEDGIKIE
1570 1580 1590 1600 1610 1620
ENSLKEEEST EGEKEVKSTA PEATVECAQP PAPAPATAPA TATAPEDDKA PAEPPEGEEK
1630 1640 1650 1660 1670 1680
VEKAEVKERT EEPMETEAKG TTEVEKVEEK SAVDLTPIVV EDKEEKKEEE EKKDVMLQNG
1690 1700 1710 1720 1730 1740
ETPKDLSDEK QKKNSKQRFM FNIADGGFTE LHSLWQNEER AATVTKKTYE IWHRRHDYWL
1750 1760 1770 1780 1790 1800
LAGIINHGYA RWQDIQNDPR YAILNEPFKG EMNRGNFLEI KNKFLARRFK LLEQALVIEE
1810 1820 1830 1840 1850 1860
QLRRAAYLNM SEDPSHPSMA LNTRFAEVEC LAESHQHLSK ESMAGNKPAN AVLHKVLKQL
1870 1880 1890 1900 1910
EELLSDMKAD VTRLPATIAR IPPVAVRLQM SERNILSRLA NRAPEPPPQQ VAQQQ